MAZE (Maze Therapeutics) Research & Development: $115.02 Mil (TTM As of Mar. 2026)


MAZE Maze Therapeutics Inc MAZE
14 GF Score
Price $26.64
! 2 Warning Signs
View Full Analysis

What is Maze Therapeutics Research & Development?

Maze Therapeutics MAZE -0.13% 14 Research & Development is $115.02 Mil as of Mar. 2026. GuruFocus rates MAZE with a GF Score™ of 14/100. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Maze Therapeutics's Research & Development for the three months ended in Mar. 2026 was $34.15 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $115.02 Mil.

Maze Therapeutics  (NAS:MAZE) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Maze Therapeutics Research & Development Related Terms

Maze Therapeutics Research & Development Historical Data

* Premium members only.

The historical data trend for Maze Therapeutics's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Maze Therapeutics Research & Development Chart

Maze Therapeutics Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Research & Development
88.19 73.95 83.50 108.45

Maze Therapeutics Quarterly Data
Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.58 28.11 25.19 27.57 34.15
MAZE
14GF Score
Maze Therapeutics Inc MAZE
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Maze Therapeutics Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $115.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $115.02 Mil mean?
Maze Therapeutics (MAZE) has a Research & Development of $115.02 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Maze Therapeutics and its competitors.
Is Maze Therapeutics' Research & Development too high?
Maze Therapeutics' current Research & Development is $115.02 Mil. Overall, Maze Therapeutics has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Maze Therapeutics' Research & Development compare to FTRE and ARDX?
Maze Therapeutics' Research & Development of $115.02 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Maze Therapeutics and its competitors. Maze Therapeutics's current Research & Development is $115.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maze Therapeutics stock overvalued right now?
Maze Therapeutics (MAZE) has a current Research & Development of $115.02 Mil. The current Research & Development is $115.02 Mil. Maze Therapeutics' overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Maze Therapeutics (MAZE), the current Research & Development is $115.02 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Maze Therapeutics Business Description

Address 171 Oyster Point boulevard, Suite 300, South San Francisco, CA, USA, 94080
Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.
14GF Score

Get the complete analysis for MAZE

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$26.64
Price